A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder

被引：0
|
作者：
Soyon Lee
Bimal Malhotra
Dana Creanga
Martin Carlsson
Paul Glue
机构：
[1] Rutgers University,Ernest Mario School of Pharmacy
[2] Pfizer Inc,Clinical Pharmacology Department
[3] Pfizer Inc,Statistics Department
[4] Dunedin School of Medicine,undefined
来源：
BMC Medical Research Methodology | / 9卷
关键词：
Stress Urinary Incontinence; Overactive Bladder; Oxybutynin; Tolterodine; Placebo Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The placebo effect in asthma drug therapy trials: A meta-analysis
    Joyce, DP
    Jackevicius, C
    Chapman, KR
    McIvor, RA
    Kesten, S
    [J]. JOURNAL OF ASTHMA, 2000, 37 (04) : 303 - 318
  • [22] THE EFFICACY AND SAFETY OF MIRABEGRON RELATIVE TO ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER NOT APPROPRIATELY MANAGED WITH AN ANTIMUSCARINIC: A NETWORK META-ANALYSIS
    Lozano-Ortega, G.
    Gooch, K.
    Walker, D.
    Rogula, B.
    Deighton, A.
    Johnston, K. M.
    Dmochowski, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S266 - S266
  • [23] Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis
    Hsiao-Ling Chen
    Tun-Chieh Chen
    Hsiu-Mei Chang
    Yung-Shun Juan
    Wei-Hsuan Huang
    Hung-Fang Pan
    Yong-Chieh Chang
    Chiou-Mei Wu
    Ya-Ling Wang
    Hsiang Ying Lee
    [J]. World Journal of Urology, 2018, 36 : 1285 - 1297
  • [24] The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis (vol 48, pg 5, 2005)
    Chapple, CR
    Khullar, V
    Gabriel, Z
    Dooley, JA
    [J]. EUROPEAN UROLOGY, 2005, 48 (05) : 875 - 875
  • [25] Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis
    Chen, Hsiao-Ling
    Chen, Tun-Chieh
    Chang, Hsiu-Mei
    Juan, Yung-Shun
    Huang, Wei-Hsuan
    Pan, Hung-Fang
    Chang, Yong-Chieh
    Wu, Chiou-Mei
    Wang, Ya-Ling
    Lee, Hsiang Ying
    [J]. WORLD JOURNAL OF UROLOGY, 2018, 36 (08) : 1285 - 1297
  • [26] Systematic Review and Meta-Analysis: Do Clinical Trials Testing Antimuscarinic Agents for Overactive Bladder Adequately Measure Central Nervous System Adverse Events?
    Paquette, Amelie
    Gou, Pauline
    Tannenbaum, Cara
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (07) : 1332 - 1339
  • [27] The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms
    Staskin, David R.
    Michel, Martin C.
    Sun, Franklin
    Guan, Zhonghong
    Morrow, Jon D.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (05): : 1721 - 1726
  • [28] Placebo response in acute treatment trials in schizophrenia: A meta-analysis
    Kane, JM
    Borenstein, M
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 284 - 284
  • [29] PLACEBO RESPONSE IN ANTIPSYCHOTIC TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Agid, Ofer
    Potkin, Steven
    Remington, Gary
    Kapur, Shitij
    Vanderburg, Douglas
    Watsky, Eric
    Siu, Cynthia
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 492 - 492
  • [30] Placebo response rates in clinical trials. A meta-analysis
    Maidhof, CH
    Dehm, C
    Walach, H
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2000, 35 (3-4) : 224 - 224
12345